The HeartMate 3™ Left Ventricular Assist Device (LVAD) is a mechanical circulatory support device designed for patients with advanced heart failure. With significantly improved outcomes and survival comparable to heart transplant at 2 years, our LVAD device technology is making a better future possible for many patients with advanced heart failure.*1-3 The HeartMate 3 LVAD has advanced the field of LVAD therapy and is setting the standard with innovation and outstanding clinical outcomes.1
The Full MagLev Flow Technology within the HeartMate 3 LVAD maintains gentle blood handling to minimize complications and hemocompatibility-related adverse events.
HeartMate 3 LVAD with Full MagLev Flow Technology Pump offers:
The HeartMate 3 Left Ventricular Assist System is indicated for providing short- and long-term mechanical circulatory support (e.g., as bridge to transplant or myocardial recovery, or destination therapy) in adult and pediatric patients with advanced refractory left ventricular heart failure and with an appropriate body surface area.
The HeartMate 3 Left Ventricular Assist System is contraindicated for patients who cannot tolerate, or who are allergic to, anticoagulation therapy.
Recognize the Stages of Heart Failure
Learn more about how to evaluate and confirm heart failure progression and what stage of HF is associated with LVAD treatment.
Patient Referral
Learn more about how to identify which heart failure patients should be considered for advanced heart failure therapies and how to refer them for a HeartMate 3 LVAD evaluation.
There are comprehensive clinical evidence materials available to learn about the survival rate and patient improvement associated with the HeartMate 3 LVAD. For a deep dive into the clinical data, visit Clinical Evidence and Momentum 3 Trial information.
MOMENTUM 3 is the largest LVAD trial ever conducted demonstrating excellent survival and safety outcomes with HeartMate 3™ LVAD.**1
The ELEVATE Registry7 evaluated the real-world experience of the HeartMate 3 LVAD in a post-approval setting. 5-year extended follow-up showed:
Our coding and reimbursement documents provide information about coverage, coding and payment, economic insights and supporting documentation for Abbott LVAD and mechanical circulatory support products.
On December 1, 2020, the Centers for Medicare and Medicaid Services (CMS) updated the final decision memo for National Coverage Determination (NCD 20.9.1) for Ventricular Assist Devices.
CMS removed the pre-implant designations (bridge-to-transplant and destination therapy) in favor of central clinical criteria for qualification of VADs for the purpose of coverage and payment effective for dates of services on and after December 1, 2020.
To access the final decision memo and the analysis in its entirety please go to cms.gov.
Mechanical Circulatory Support (MCS) Coding Guide
This Medicare coding and payment guide covers the HeartMate 3™ LVAS and other mechanical circulatory support products.
Abbott Coverage and Frequently Asked Questions Guide Mechanical Circulatory Support
This guide provides coverage and reimbursement information for the implantable HeartMate 3 Left Ventricular Assist Device (LVAD) and other procedures.
This link offers a current list of reimbursement Healthcare Procedural Coding System Device Category C-codes.
For the full resource list, visit Reimbursement & Coding for left ventricular assist devices.
*Based on published data from separate datasets, which may involve different patient populations and other variables. Not a head-to-head comparison. Data presented for informational purposes only.
**HeartMate 3 LVAD demonstrated superiority in event-free survival (primary endpoint) in the MOMENTUM 3 trial compared to HeartMate II™ LVAD.
§For a continuous-flow LVAD in a randomized controlled trial.
MAT-2012548 v2.0
Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
Precautions
Please be sure to read it.
The following pages are intended for medical professionals and provide information on the proper use of products (medical devices, etc.) of Abbott Medical Japan GK.
The information provided here is not intended to provide information to patients and the general public.
Are you a healthcare professional?
Test